Patients Coinfected With Hcv And Hiv Who Achieve An Rvr (Hcv Rna < 50 Iu/Ml At Week 4) Or Cevr (Hcv Rna < 50 Iu/Ml At Week 12) Have Similar Rates Of Svr To Monoinfected Patients Treated With Peginterferon Alfa-2a (40kd) (Pegasys (R)) And Ribavirin (Copegus (R))